HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhide Hayashi Selected Research

Eosinophil Cationic Protein

12/2016IP-10 Is Elevated in Virus-Induced Acute Exacerbations in Childhood Asthma.
9/2015Virus detection and cytokine profile in relation to age among acute exacerbations of childhood asthma.
2/2011Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing.
1/2011Differential effects of corticosteroids on serum eosinophil cationic protein and cytokine production in rhinovirus- and respiratory syncytial virus-induced acute exacerbation of childhood asthma.
1/2010Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhide Hayashi Research Topics

Disease

21Neoplasms (Cancer)
01/2021 - 08/2002
13Leukemia
10/2019 - 07/2002
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2018 - 01/2002
8Asthma (Bronchial Asthma)
12/2016 - 01/2006
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2014 - 05/2002
7Neuroblastoma
01/2021 - 10/2003
7Lymphoma (Lymphomas)
10/2019 - 12/2003
3Disease Progression
02/2005 - 09/2002
3Hematologic Neoplasms (Hematological Malignancy)
08/2002 - 01/2002
2Philadelphia Chromosome
07/2015 - 02/2005
2Inflammation (Inflammations)
01/2013 - 01/2012
2Necrosis
01/2012 - 06/2009
2Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2011 - 10/2008
2Myeloid Leukemia (Leukemia, Myelocytic)
08/2009 - 04/2005
2Pathologic Complete Response
05/2009 - 10/2008
2Down Syndrome (Down's Syndrome)
02/2008 - 10/2003
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2007 - 02/2005
2Carcinogenesis
04/2005 - 10/2003
2Rhabdomyosarcoma
10/2003 - 09/2003
2Ewing Sarcoma (Sarcoma, Ewing)
10/2003 - 09/2003
2Residual Neoplasm
09/2003 - 01/2003
1Disseminated Intravascular Coagulation
05/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2021
1Jaundice (Icterus)
05/2021
1Edema (Dropsy)
05/2021
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2019
1Virus Diseases (Viral Diseases)
12/2016
1Leukopenia
04/2014
1Rhabdoid Tumor (Rhabdoid Tumors)
03/2014
1autosomal recessive distal Renal tubular acidosis
08/2013
1Cytomegalovirus Retinitis
03/2013
1Infections
01/2013
1Gastroesophageal Reflux (GERD)
01/2013
1Pathologic Constriction (Stenosis)
01/2013
1Body Weight (Weight, Body)
01/2013
1Respiratory Syncytial Virus Infections
01/2013
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
11/2012
1Leukocytosis (Pleocytosis)
08/2012
1Eosinophilia
05/2012
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
02/2012
1Respiratory Sounds (Crackle)
02/2011

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
11/2012 - 01/2002
7CytokinesIBA
12/2016 - 08/2009
7DNA (Deoxyribonucleic Acid)IBA
09/2015 - 01/2003
7Phosphotransferases (Kinase)IBA
02/2011 - 02/2005
5ChemokinesIBA
12/2016 - 01/2010
5Eosinophil Cationic ProteinIBA
12/2016 - 01/2010
5Interleukin-5 (Interleukin 5)IBA
12/2016 - 01/2010
5nuclear pore complex protein 98IBA
02/2016 - 01/2002
3Pharmaceutical PreparationsIBA
01/2020 - 02/2005
3Biological ProductsIBA
01/2019 - 12/2003
3AntigensIBA
09/2015 - 02/2011
3Messenger RNA (mRNA)IBA
10/2012 - 05/2002
3Imatinib Mesylate (Gleevec)FDA Link
02/2007 - 02/2005
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2005 - 05/2002
2RNA (Ribonucleic Acid)IBA
01/2021 - 10/2019
2fms-Like Tyrosine Kinase 3IBA
05/2018 - 10/2007
2Core Binding Factors (Core-Binding Factor)IBA
10/2017 - 05/2012
2Immunoglobulin E (IgE)IBA
12/2016 - 05/2014
2Transcription Factors (Transcription Factor)IBA
07/2015 - 10/2003
2OligonucleotidesIBA
03/2014 - 12/2003
2Anaplastic Lymphoma KinaseIBA
02/2011 - 10/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2011 - 04/2005
2Interleukin-6 (Interleukin 6)IBA
02/2011 - 01/2011
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2011 - 01/2010
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2011 - 01/2010
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2011 - 01/2010
2Protein Isoforms (Isoforms)IBA
06/2010 - 07/2005
2Prednisolone (Predate)FDA LinkGeneric
08/2008 - 09/2005
2trioctyl phosphine oxide (TOPO)IBA
11/2004 - 07/2003
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2003 - 11/2002
2Nuclear Pore Complex Proteins (Nucleoporins)IBA
08/2002 - 01/2002
1BilirubinIBA
05/2021
1Biomarkers (Surrogate Marker)IBA
05/2021
1Proline (L-Proline)FDA Link
01/2021
1EnzymesIBA
01/2019
1salicylhydroxamic acid (SHAM)IBA
11/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2017
1NucleotidesIBA
11/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2015
1AntibodiesIBA
05/2014
1AllergensIBA
05/2014
1dirhodium tetraacetate (DRTA)IBA
08/2013
1OvalbuminIBA
01/2013
1SteroidsIBA
01/2013
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
01/2013
1Interleukin-17 (Interleukin 17)IBA
01/2013
1Prednisone (Sone)FDA LinkGeneric
02/2012
1Trypan BlueFDA Link
01/2012
1Eosinophil Granule ProteinsIBA
01/2012
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2011

Therapy/Procedure

12Therapeutics
01/2021 - 09/2002
8Drug Therapy (Chemotherapy)
04/2014 - 11/2004
2Hematopoietic Stem Cell Transplantation
08/2012 - 12/2004
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2010 - 05/2009
1Induction Chemotherapy
10/2012
1Stem Cell Transplantation
02/2012
1Remission Induction
02/2012
1Radiotherapy
02/2011